Aragen Life Sciences files draft papers with SEBI; eyes ₹800-cr via fresh issue
An offer for sale (OFS) of 2.73 crore equity shares will be made by selling shareholders, per the draft red herring prospectus (DRHP) filed Wednesday
We haven't written up this one. Hindu BusinessLine has the full story — the link below goes straight to it.